NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 343 filers reported holding NATERA INC in Q2 2021. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $403,826 | -43.9% | 9,126 | -38.3% | 0.00% | -25.0% |
| Q2 2023 | $720,168 | +22.4% | 14,800 | +39.6% | 0.00% | 0.0% |
| Q1 2023 | $588,512 | -41.9% | 10,600 | -58.0% | 0.00% | -50.0% |
| Q4 2022 | $1,013,007 | -8.3% | 25,218 | 0.0% | 0.01% | +14.3% |
| Q3 2022 | $1,105,000 | -77.5% | 25,218 | -81.8% | 0.01% | -75.9% |
| Q2 2022 | $4,908,000 | -7.1% | 138,498 | +6.7% | 0.03% | +20.8% |
| Q1 2022 | $5,282,000 | -55.7% | 129,832 | +1.7% | 0.02% | -46.7% |
| Q4 2021 | $11,928,000 | -9.9% | 127,718 | +7.5% | 0.04% | -16.7% |
| Q3 2021 | $13,244,000 | +120.2% | 118,840 | +124.3% | 0.05% | +107.7% |
| Q2 2021 | $6,015,000 | +1135.1% | 52,979 | +1004.9% | 0.03% | +766.7% |
| Q1 2021 | $487,000 | -52.2% | 4,795 | -53.1% | 0.00% | -50.0% |
| Q4 2020 | $1,018,000 | – | 10,231 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |